PF-08634404, Sigvotatug vedotin clinical trials

C6461020 - An Interventional Open-Label Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 in combination with Different Anticancer Agents in Participants with Advanced Solid Tumors

This study is testing a new combination of treatments, including a medicine called PF-08634404, for people with advanced solid tumours. It aims to see how safe the treatments are and how well they work together against cancer.